PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.
about
Characterization of Spi-B, a transcription factor related to the putative oncoprotein Spi-1/PU.1E2A and IRF-4/Pip promote chromatin modification and transcription of the immunoglobulin kappa locus in pre-B cells.Characterization of NERF, a novel transcription factor related to the Ets factor ELF-1Assembly requirements of PU.1-Pip (IRF-4) activator complexes: inhibiting function in vivo using fused dimersThe conserved 5'-untranslated leader of Spi-1 (PU.1) mRNA is highly structured and potently inhibits translation in vitro but not in vivoSolution structure of the ETS domain from murine Ets-1: a winged helix-turn-helix DNA binding motifSimple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identitiesPhosphorylation of E47 as a potential determinant of B-cell-specific activityLineage-specific modulation of interleukin 4 signaling by interferon regulatory factor 4Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1Transcription factor binding sites in the pol gene intragenic regulatory region of HIV-1 are important for virus infectivitySPI-B activates transcription via a unique proline, serine, and threonine domain and exhibits DNA binding affinity differences from PU.1AKT induces transcriptional activity of PU.1 through phosphorylation-mediated modifications within its transactivation domainPU.1 is essential for p47(phox) promoter activity in myeloid cellsThe transcription factor Spi-1/PU.1 interacts with the potential splicing factor TLSThe transcription factor Spi-1/PU.1 binds RNA and interferes with the RNA-binding protein p54nrbActivating transcription factor 1 and cyclic AMP response element modulator can modulate the activity of the immunoglobulin kappa 3' enhancerRepression of I-A beta gene expression by the transcription factor PU.1Physical interaction and functional synergy between glucocorticoid receptor and Ets2 proteins for transcription activation of the rat cytochrome P-450c27 promoterAn inhibitory carboxyl-terminal domain in Ets-1 and Ets-2 mediates differential binding of ETS family factors to promoter sequences of the mb-1 geneThe NIMA-family kinase Nek3 regulates microtubule acetylation in neuronsSpi-C, a novel Ets protein that is temporally regulated during B lymphocyte development.Prf, a novel Ets family protein that binds to the PU.1 binding motif, is specifically expressed in restricted stages of B cell development.Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU.Potential autoregulation of transcription factor PU.1 by an upstream regulatory elementMultiple functional domains of AML1: PU.1 and C/EBPalpha synergize with different regions of AML1Normal myeloid development requires both the glutamine-rich transactivation domain and the PEST region of transcription factor PU.1 but not the potent acidic transactivation domain.BSAP can repress enhancer activity by targeting PU.1 function.Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B.Regulation of Ets function by protein - protein interactions.Synergistic activation of the HTLV1 LTR Ets-responsive region by transcription factors Ets1 and Sp1.PU.1 is involved in the regulation of B lineage-associated and developmental stage-dependent expression of the germinal center-associated DNA primase GANP.EBV-encoded LMP1 upregulates Igκ 3'enhancer activity and Igκ expression in nasopharyngeal cancer cells by activating the Ets-1 through ERKs signaling.The transcription factors IRF8 and PU.1 negatively regulate plasma cell differentiation.Mouse mu opioid receptor gene expression. A 34-base pair cis-acting element inhibits transcription of the mu opioid receptor gene from the distal promoterIdentification of a PU.1-IRF4 protein interaction surface predicted by chemical exchange line broadeningCD18 (beta 2 leukocyte integrin) promoter requires PU.1 transcription factor for myeloid activity.A compilation of composite regulatory elements affecting gene transcription in vertebrates
P2860
Q24293686-094C24E1-C19F-40EC-8FB6-22495D5FBC01Q24301680-A9C1418D-9650-4087-BEC0-3E46503723BDQ24316274-231279FF-5899-459D-9DFE-C0E52A4BA7B6Q24533589-0CFFB3EC-59EC-4C17-BADC-5298C6DAA9C7Q24544980-FABA2CE2-D0BA-463C-A139-88BB86193A65Q24563315-7BEE1A91-9812-4786-9074-C33C6DFD3BB2Q24617969-D456F050-6E1B-4BBF-B282-415A7AFAC1FBQ24647666-F1C15267-E749-40B5-ABC3-D163DD5D9B99Q24671741-F95BB3C0-8501-4297-86FB-E980A9AA093CQ24671782-46101CA1-9416-41FA-B952-5D715E64A65BQ24815940-AA20E9B2-67A9-4825-8160-9CFC4E9F009CQ28119191-2388ADBA-3CB4-440D-AC7F-BBD9DF2EFCC8Q28141194-0CBD0542-D405-476A-AADF-FBFCA770AD98Q28243008-B26EF1BD-DFA5-42E3-97C4-6B9DD7E9E2E5Q28262912-BE9E139E-3B4A-4C62-BE03-3F1D4C760FC9Q28278347-439275F5-B103-4D65-8822-9C8DB318433CQ28300492-3757CF4F-A7AA-4729-8C46-F306B1653AE1Q28511025-BF10B6EE-4AC6-423A-9C23-4EDC38C52F2DQ28581645-BD5C112B-CA6E-4B8F-8AE0-16A67B92F978Q28586875-B84AF13A-EE7D-4000-B4EF-21947C0515ECQ28594737-981B3CD9-BEA2-4D7B-9FB9-E04FF69736A3Q30667280-FDA91B0E-765D-490F-AAA6-62ED92DB3F93Q30760665-7DB1AD7E-E747-462C-A9E0-E482FE738D10Q33613910-112284E8-F5A3-4BBF-B3A8-9C134F43C018Q33707708-FF6D6084-A6D6-4294-9B9E-D4FFDC2F775DQ33774804-3D621D03-35C0-4D78-9CF8-76F0E51FB94EQ33775074-EEF26F35-987F-48C5-AC0C-CB82287A310FQ33786904-B477A0EB-4187-48F0-A8EF-F7DF1F21E6ABQ33787090-55A48359-CFEF-477C-9484-7A9BAEF9ABA6Q33887496-5D199224-AC61-4498-BD00-D7AA9C3F37DCQ33887829-58EF375B-2D9B-47A7-90DE-91F54800E790Q33933221-F1F0BB96-8338-45D5-A3F2-BDF32E2C654FQ34046598-423DA509-1408-4F7E-A65A-099B7BA5CBFFQ34098003-2EF09251-6868-402D-97EA-0F7B97155BC8Q34187244-16BEE2CF-AD33-4166-8E83-D0A95D5C0FEBQ34375208-CDCE21A4-4E92-491C-92DF-214B0F1C2C1FQ34401595-E1B4C3B0-B43D-4953-B8F2-A8CA9F2ED43EQ34470052-0EA00D33-10B4-459E-814C-D8A2C6346265Q34734315-B741DCA5-D10A-4D27-8CBC-F30E96C9353DQ34776433-17558315-BA5E-41FD-9187-A23695BC09FC
P2860
PU.1 recruits a second nuclear factor to a site important for immunoglobulin kappa 3' enhancer activity.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
PU.1 recruits a second nuclear ...... in kappa 3' enhancer activity.
@ast
PU.1 recruits a second nuclear ...... in kappa 3' enhancer activity.
@en
type
label
PU.1 recruits a second nuclear ...... in kappa 3' enhancer activity.
@ast
PU.1 recruits a second nuclear ...... in kappa 3' enhancer activity.
@en
prefLabel
PU.1 recruits a second nuclear ...... in kappa 3' enhancer activity.
@ast
PU.1 recruits a second nuclear ...... in kappa 3' enhancer activity.
@en
P2093
P2860
P356
P1476
PU.1 recruits a second nuclear ...... in kappa 3' enhancer activity.
@en
P2093
J M Pongubala
M J Klemsz
M L Atchison
S Nagulapalli
S R McKercher
P2860
P304
P356
10.1128/MCB.12.1.368
P407
P577
1992-01-01T00:00:00Z